Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy
Description
Autosomal dominant neovascular inflammatory vitreoretinopathy is a rare, genetic, vitreoretinal degeneration characterized by a slowly progressive vitreoretinopathy with onset during the second or third decade of life. The disease initially presents as autoimmune uveitis with reduction in the b-wave on electroretinography, and progresses with development of photoreceptor degeneration, vitreous hemorrhage, cystoid macular edema, retinal neovascularization, intraocular fibrosis, secondary glaucoma, and retinal detachment leading to phthisis and complete blindness.
Genes related to Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy
- CAPN5
Clinical Features
Top most frequent phenotypes and symptoms related to Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy
- Cataract
- Edema
- Blindness
- Visual loss
- Rod-cone dystrophy
- Glaucoma
- Abnormality of the eye
- Retinopathy
- Retinal degeneration
- Retinal detachment
And another 16 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy Is also known as adniv, pvr, vitreoretinopathy, neovascular inflammatory, autosomal dominant, proliferative vitreoretinopathy.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Comprehensive Vitreoretinopathy Sequencing Panel with CNV Detection.
By PreventionGenetics PreventionGenetics (United States).
ATOH7, CAPN5, RCBTB1, ATP6V0A2, ZNF408, TSPAN12, VCAN, CTNNB1, ISPD, FZD4, KIF11, LRP5, NDP
Specificity
8 %
Genes
100 % |
Comprehensive Inherited Retinal Dystrophies (includes RPGR ORF15) Sequencing Panel with CNV Detection.
By PreventionGenetics PreventionGenetics (United States).
RGS9, RHO, GRK1, RLBP1, ROM1, RP1, RP2, RP9, RPE65, RPGR, RS1, CNNM4, SAG, SDCCAG8, SEMA4A, SLC24A1, SLC4A7, SPP2, PLK4, TEAD1 , (...)
View the complete list with 286 more genes
Specificity
1 %
Genes
100 % |
Vitreoretinopathy, Neovascular Inflammatory via CAPN5 Gene Sequencing with CNV Detection.
By PreventionGenetics PreventionGenetics (United States).
CAPN5
Specificity
100 %
Genes
100 % |
Exudative vitreoretinopathy Deletion / Duplication panel.
By Connective Tissue Gene Tests (United States).
CAPN5, ZNF408, TSPAN12, FZD4, KIF11, LRP5, NDP
Specificity
15 %
Genes
100 % |
Exudative vitreoretinopathy Comprehensive panel.
By Connective Tissue Gene Tests (United States).
CAPN5, ZNF408, TSPAN12, FZD4, KIF11, LRP5, NDP
Specificity
15 %
Genes
100 % |
Exudative vitreoretinopathy NGS panel.
By Connective Tissue Gene Tests (United States).
CAPN5, ZNF408, TSPAN12, FZD4, KIF11, LRP5, NDP
Specificity
15 %
Genes
100 % |
Vitreoretinopathy Comprehensive panel.
By Connective Tissue Gene Tests (United States).
RS1, BEST1, CAPN5, ZNF408, TSPAN12, COL11A1, COL11A2, COL18A1, COL9A1, COL9A2, COL9A3, VCAN, FZD4, KCNJ13, KIF11, LRP5, NDP, NR2E3
Specificity
6 %
Genes
100 % |
Vitreoretinopathy Deletion / Duplication panel.
By Connective Tissue Gene Tests (United States).
RS1, BEST1, CAPN5, ZNF408, TSPAN12, COL11A1, COL11A2, COL18A1, COL9A1, COL9A2, COL9A3, VCAN, FZD4, KCNJ13, KIF11, LRP5, NDP, NR2E3
Specificity
6 %
Genes
100 % |
You can get up to 8 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET OMIM Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like VISCERAL MYOPATHY; VSCM PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, TORRANCE TYPE; PLSDT HYDROLETHALUS SYNDROME 2; HLS2